These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 33798650)

  • 21. Non-antibiotic antimicrobial interventions and antimicrobial stewardship in wound care.
    Cooper R; Kirketerp-Møller K
    J Wound Care; 2018 Jun; 27(6):355-377. PubMed ID: 29883284
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Can public financing of the private sector defeat antimicrobial resistance?
    James JE
    J Public Health (Oxf); 2019 Jun; 41(2):422-426. PubMed ID: 29982521
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immunocontinuum: perspectives in antimicrobial peptide mechanisms of action and resistance.
    Yount NY; Yeaman MR
    Protein Pept Lett; 2005 Jan; 12(1):49-67. PubMed ID: 15638803
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antimicrobial peptides: primeval molecules or future drugs?
    Peters BM; Shirtliff ME; Jabra-Rizk MA
    PLoS Pathog; 2010 Oct; 6(10):e1001067. PubMed ID: 21060861
    [No Abstract]   [Full Text] [Related]  

  • 25. Antimicrobial resistance: A multifaceted problem with multipronged solutions.
    Gil-Gil T; Laborda P; Sanz-García F; Hernando-Amado S; Blanco P; Martínez JL
    Microbiologyopen; 2019 Nov; 8(11):e945. PubMed ID: 31724836
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A global call for action to combat antimicrobial resistance: can we get it right this time?
    Mendelson M; Matsoso MP
    S Afr Med J; 2014 Jun; 104(7):478-9. PubMed ID: 25214047
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Host-directed therapies for bacterial and viral infections.
    Kaufmann SHE; Dorhoi A; Hotchkiss RS; Bartenschlager R
    Nat Rev Drug Discov; 2018 Jan; 17(1):35-56. PubMed ID: 28935918
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Resistance of urinary tract pathogens and the choice of antimicrobial therapy: deceptive simplicity].
    Rafalskiy VV; Dovgan EV
    Urologiia; 2017 Jul; (3):104-110. PubMed ID: 28845948
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Barriers to the effective treatment of sepsis: antimicrobial agents, sepsis definitions, and host-directed therapies.
    Lyle NH; Pena OM; Boyd JH; Hancock RE
    Ann N Y Acad Sci; 2014 Sep; 1323():101-14. PubMed ID: 24797961
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antimicrobial Stewardship Programs: Principles and Practice.
    Cunha CB
    Med Clin North Am; 2018 Sep; 102(5):797-803. PubMed ID: 30126571
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Effector molecules of the innate immune system for treatment of wound infections].
    Steinsträsser L; Langer S; Lehnhardt M; Steinau HU
    Chirurg; 2007 Apr; 78(4):343-8. PubMed ID: 17377758
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antimicrobial immunotherapeutics: past, present and future.
    Mercer DK; Francis ML; Fraser-Pitt D
    Emerg Top Life Sci; 2021 Nov; 5(5):609-628. PubMed ID: 34196722
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Update on antimicrobial agents: new indications of older agents.
    Pasquale TR; Tan JS
    Expert Opin Pharmacother; 2005 Aug; 6(10):1681-91. PubMed ID: 16086654
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Crisis in Infectious Diseases: 2 Decades Later.
    Casadevall A
    Clin Infect Dis; 2017 Apr; 64(7):823-828. PubMed ID: 28362950
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Temporins, anti-infective peptides with expanding properties.
    Mangoni ML
    Cell Mol Life Sci; 2006 May; 63(9):1060-9. PubMed ID: 16572270
    [TBL] [Abstract][Full Text] [Related]  

  • 36. On the physiology and pathophysiology of antimicrobial peptides.
    Pálffy R; Gardlík R; Behuliak M; Kadasi L; Turna J; Celec P
    Mol Med; 2009; 15(1-2):51-9. PubMed ID: 19015736
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Strategies for minimizing antimicrobial resistance.
    Pflomm JM
    Am J Health Syst Pharm; 2002 Apr; 59(8 Suppl 3):S12-5. PubMed ID: 11977861
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The innate host response in caries and periodontitis.
    Meyle J; Dommisch H; Groeger S; Giacaman RA; Costalonga M; Herzberg M
    J Clin Periodontol; 2017 Dec; 44(12):1215-1225. PubMed ID: 28727164
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lipopolysaccharide neutralization by antimicrobial peptides: a gambit in the innate host defense strategy.
    Pulido D; Nogués MV; Boix E; Torrent M
    J Innate Immun; 2012; 4(4):327-36. PubMed ID: 22441679
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Novel anti-infectives: is host defence the answer?
    Hamill P; Brown K; Jenssen H; Hancock RE
    Curr Opin Biotechnol; 2008 Dec; 19(6):628-36. PubMed ID: 19000763
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.